Electronic device on trial for osteoporosis treatment
This article was originally published in Clinica
The FDA has approved a clinical trial by researchers at the National Osteoporosis Institute (NOI) in Long Island, New York, of a bone growth stimulator for treating osteoporois is designed as a chair pad on which the patient sits for several hours a day. The device, developed by Orthofix International, is based on the company's pulsed electromagnetic field (PEMF) technology, used in a variety of its bone growth stimulators, including Spinal-Stim Lite and Physio-Stim Lite.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.